on REPLOID Group AG (isin : AT0000A3HRX5)
REPLOID Group AG Acquires Stake in HEROSAN Healthcare GmbH
On October 3, 2025, REPLOID Group AG announced its acquisition of a stake in HEROSAN Healthcare GmbH, marking a strategic move into the sustainable animal feed market. The acquisition is set to occur in two phases, with more than 30% being acquired in 2025, and a complete takeover planned for 2026.
HEROSAN focuses on Europe-wide growth with an emphasis on sustainability in animal nutrition. The company's offerings include feed mixes utilizing hemp and insect protein, functional mushroom components, and select meat products. By acquiring HEROSAN, REPLOID aims to capitalize on the growing demand for premium animal feed products.
This investment seeks to position HEROSAN as a leading feed producer in Europe, expanding REPLOID’s investment portfolio into a high-growth market segment.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all REPLOID Group AG news